Scinai Immunotherapeutics Establishes U.S. Subsidiary For CDMO Business Unit, Scinai Bioservices Inc.
(MENAFN- PR Newswire) JERUSALEM, Dec. 16, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI ) ("Scinai" or the "Company"), a biopharmaceutical company focused on developing inflammation and immunology (I&I) …